Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis

  • 0Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

|

|

Summary

This summary is machine-generated.

Tissue-resident alveolar macrophages induce dormancy in breast cancer cells through transforming growth factor-beta 2 (TGF-β2) signaling, preventing lung metastasis. Downregulation of this TGF-β2 pathway allows cancer cells to awaken and proliferate.

Area Of Science

  • Oncology
  • Immunology
  • Cell Biology

Background

  • Breast cancer cells can disseminate to the lungs and remain dormant.
  • Mechanisms controlling breast cancer cell dormancy in the lungs are not fully understood.
  • Tissue-resident alveolar macrophages are implicated in suppressing metastasis.

Purpose Of The Study

  • To investigate the role of alveolar macrophages in maintaining breast cancer cell dormancy in the lungs.
  • To elucidate the molecular mechanisms by which alveolar macrophages suppress cancer cell proliferation.
  • To identify signaling pathways involved in the transition from dormancy to active metastasis.

Main Methods

  • Ligand-receptor mapping to identify molecular interactions.
  • Intravital imaging to visualize macrophage-cancer cell dynamics in vivo.
  • Experimental depletion of alveolar macrophages.
  • Genetic manipulation of TGF-β2 receptor expression in cancer cells.

Main Results

  • Alveolar macrophages express transforming growth factor-beta 2 (TGF-β2).
  • TGF-β2 signaling, mediated by the TGF-βRIII receptor on cancer cells, maintains cancer cell dormancy.
  • Depletion of alveolar macrophages or loss of TGF-βRIII in cancer cells leads to metastatic awakening.
  • Aggressive breast cancer cells evade dormancy by downregulating TGF-βRIII or avoiding macrophage interaction.

Conclusions

  • Alveolar macrophages function as a critical immune barrier against breast cancer lung metastasis.
  • TGF-β2 signaling is essential for macrophage-mediated suppression of cancer cell growth.
  • Downregulation of the TGF-β2 pathway enables breast cancer cells to overcome dormancy and proliferate, leading to overt metastasis.